Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

Cholamandalam Investment and Finance - Lower provisions a surprise; strong focus on sustainable cost efficiencies - ICICI Securities

Posted On: 2020-08-03 08:43:56

Cholamandalam (Chola) delivered a comprehensive beat on PAT (Rs4.3bn vs I-Sec: Rs2.7bn) despite minor miss on operating profit. This was primarily because of lower credit costs of Rs562mn, down 49% YoY. Chola exuded confidence in the adequacy of its Covid/macro provisions and chose not to make additional accelerated provisions in Q1FY21. Cumulative Covid/macro provisions stood at ~87bps of AUM. Asset quality improved 50bps QoQ, primarily led by write-offs (>Rs1.2bn) of some fully provided assets. Moratorium was broadly unchanged (~74%) except that ~50% moratorium customers have made partial or full EMI payments. Chola reported massive market share gains as the momentum of new disbursements witnessed an improving trend especially in tractors, new passenger vehicles, two wheelers and used vehicles. We see an opportunity for Chola to deliver industry-leading asset quality and lower credit costs in an otherwise tough fiscal year. Maintain BUY with a target price of Rs262 (2.0x FY22E P/BV).

- Has Chola under provided/ adequately provided and is this a statement of confidence in its superior underwriting and collections? While one might think (we were no exceptions) Chola should have made aggressive provisioning even in Q1FY21 to build a higher cushion, we get comfort from the fact that Chola has historically always remained conservative and erred on the side of caution. While it is only natural to compare Chola's aggregate Covid/macro provisioning buffer (~87bps) with its close peers (Chart 4,5), it should be seen in the context of Chola's consistent delivery of superior asset quality and through-cycle lower credit costs (Chart 6). Management highlighted it had the benefit of knowing about extension of three-month moratorium before it arrived at Covid/macro provisions made in Q4FY20.

- Product mix changing in favour of higher-yielding assets but we still build in margin compression in FY21E and FY22E: While Chola was largely dependent on bank borrowings in the last five quarters, it has started seeing some traction in debt markets as evident in the higher quantum of debentures/CP in the borrowing mix. While incremental COB has come down, so have yields. Combined with negative from high levels of liquidity on the balance sheet, we build in NIM compression of ~40bps in the current and next fiscal.

- Asset quality and credit costs will be a function of collection efficiency post moratoriums: We give credit where it is due. Chola's moratorium disclosures were very comprehensive - it published details of collections and vintage of its moratorium customers (Chart 2,3). It effected write-offs of ~Rs330mn in its legacy agri-book and ~Rs800mn in its vehicle book (vehicles loans which were >36months old were fully written off). We anticipate asset quality to deteriorate to 4.7% by FY21-end and given the inherent uncertainties on collections in the face of localised lockdowns, we remain conservative and model elevated credit costs of 165bps/130bps in FY21E/FY22E.

- Massive market share gains in vehicle finance: Though it could be transitory but this vindicates its ability to turn adversity into opportunity. Share of vehicle finance improved YoY from 1.7% to 3.99% in Q1FY21. Likewise, market share doubled in passenger vehicles, two wheelers (on a small base), tractors and construction equipment. These market share gains would have come at the expense of smaller/weaker vehicle-finance NBFCs since its better credit-rated peers did not have any liquidity challenges and have suggested that they maintained (or slightly improved) their market share. Chola expanded across the country in tractor segment and new OEMs. In the quarter, Chola was on-boarded as a preferred financier for one of the top tractor OEMs.

- Outlook and our view on the stock remains intact: FY21 will unarguably be a tough fiscal for all vehicle financiers. Even Chola will not remain insulated and could witness sharp asset quality deterioration in H2FY21 and consequent high credit costs (we have built that in our estimates). It will tread cautiously in its LAP segment. However, any blip also offers an entry-point for long-term discerning investors in this strong franchise. Chola has navigated past credit cycles better than peers primarily due to its differentiated underwriting and strong collection focus. This will be strengthened further given Chola's strong focus on integrating data analytics to augment its physical underwriting skills (thrust on phygital). We even expect it to deliver sustainable cost efficiencies by cutting across discretionary expenses, rationalisation of branch network and emphasising productivity improvements.

- Valuations and risks: Valuation premium that Chola used to command over its peers has come off slightly. Current valuations at 1.5x FY22E P/BV still reflect its relatively superior asset quality and higher earnings predictability. Our target multiple of 2.0x FY22E P/BV leads to a revised target price of Rs262 (earlier: Rs273). Maintain BUY. Slippages in collection efficiency after moratorium period, higher competitive intensity from banks/SFBs and deterioration in asset quality, particularly in home equity portfolio, remain key risks.

Shares of Cholamandalam Investment and Finance Company Ltd was last trading in BSE at Rs.201.35 as compared to the previous close of Rs. 202.5. The total number of shares traded during the day was 324230 in over 5647 trades.

The stock hit an intraday high of Rs. 206.45 and intraday low of 196.95. The net turnover during the day was Rs. 65399825.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:


Mutual Fund Review - September, 2020 - ICICI Securities

UTI AMC announces IPO date - Angel Broking

Asian Paints - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Britannia Industries - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Hexaware Technologies (Not Rated): Hexaware accepts 475/share as final delisting price - ICICI Securities

CAMS IPO - Day 2 Subscription - Angel Boking

Chemcon Speciality Chemicals - IPO subscribed 12.62 times on second day - Angel Broking

General insurance - Fire, health remain growth drivers, rising Covid claims a concern - ICICI Securities

Supreme Industries - Perfect recipe for rerating; upgrade to BUY - ICICI Securities

Titan Company - Best positioned to gain from faster-than-expected recovery. Upgrade to ADD - ICICI Securities

Sector Update - Telecom - Sep 23, 2020 - ICICI Securities

Allcargo Logistics - Highlights of Blackstone deal - ICICI Securities

I-direct Instinct - Gokaldas Exports

Economy: RBI's trilemma: allows for INR strength - Kotak

HCL Technologies - Company Update - ICICI Securities

Chemcon Speciality Chemicals - IPO Review - ICICI Securities

Angel Broking - IPO Note - YES Securities

TCS - Announcement of its blockhchain based solutions on Microsoft Azure - Angel Broking

Amber Enterpirses acquire Sidwal - Angel Broking

Dixon Technologies - Buy - YES Securities

HCL Technologies acquisition of DWS Limited - Angel Broking

Allcargo Logistics CFO Resignation - Angel Broking

Upgrade to BUY on Gateway Distriparks - Strengthening the balance sheet - HDFC Securities

BUY on ITD Cementation - Execution pickup awaited - HDFC Securities

Allcargo Logistics - Trying to stich through an integrated offering - ICICI Securities

Polymer price tracker - Other polymer (ex-PVC) prices too firm up - ICICI Securities

Angel Broking - IPO Review - ICICI Securities

IPO Review - Computer Age Management Services - ICICI Securities

Company Update - EIH Ltd - ICICI Securities

Gladiator Stocks - Godrej Properties - ICICI Securities

Company Update - Dr Reddy's Laboratories - ICICI Securities

Gladiator Stocks: Pharma Thematic - ICICI Securities

Company Update - Housing & Urban Development - ICICI Securities

Covid Recovery Pulse - E-Way bill generation shows recovery signs with auto volumes flat - ICICI Securities

Quant Pick - UltraTech Cement - ICICI Securities

Lupin & Cipla - Positive News - Angel Broking

Sterling and Wilson Solar Ltd - 106.71 MW order win - Angel Broking

Dr. Reddy's Laboratories - Settles Revlimid litigation in US - ICICI Securities

Natco Pharma - Natco to launch first generic Revlimid - ICICI Securities

Solar Industries - Overseas and defence key to profitability - ICICI Securities

Federal Bank - Strengthening liability muscle; fees & charges revised upwards - ICICI Securities

HCL Technologies Mr. Jyoti Roy, DVP - Equity Strategist, Angel Broking Ltd


I-direct Instinct - Intellect Design Arena

P&G Health - Company Update - ICICI Securities

Relaxo Footwears - Mr. Amarjeet Maurya- AVP - Mid Caps, Angel Broking Ltd

Bata India - Mr. Amarjeet Maurya- AVP - Mid Caps, Angel Broking Ltd

Listing of Happiest Minds Technologies - Angel Broking

Dr. Reddy's Lab - Sep 17, 2020 - Angel Broking

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019